DNB Asset Management AS Sells 46,223 Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY)
DNB Asset Management AS reduced its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 2.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,004,053 shares of the medical instruments supplier’s stock after selling 46,223 shares during the quarter. DENTSPLY SIRONA accounts for about 1.3% of DNB Asset Management AS’s investment portfolio, making the stock its 14th largest holding. DNB Asset Management AS owned about 0.86% of DENTSPLY SIRONA worth $116,957,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in XRAY. Pinnacle Bank bought a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $26,000. Hanseatic Management Services Inc. bought a new position in shares of DENTSPLY SIRONA during the first quarter worth about $30,000. Private Capital Group LLC grew its holdings in shares of DENTSPLY SIRONA by 74.7% during the first quarter. Private Capital Group LLC now owns 1,223 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 523 shares in the last quarter. Quadrant Capital Group LLC grew its holdings in shares of DENTSPLY SIRONA by 1,047.2% during the first quarter. Quadrant Capital Group LLC now owns 1,411 shares of the medical instruments supplier’s stock worth $68,000 after buying an additional 1,288 shares in the last quarter. Finally, Cullen Frost Bankers Inc. bought a new position in shares of DENTSPLY SIRONA during the first quarter worth about $104,000. Institutional investors own 91.62% of the company’s stock.
A number of research analysts recently issued reports on XRAY shares. Barrington Research decreased their price objective on CBS from $72.00 to $60.00 and set an “outperform” rating for the company in a report on Monday, May 6th. HC Wainwright reissued a “neutral” rating and set a $57.00 price target (up from $55.00) on shares of DENTSPLY SIRONA in a research report on Tuesday, July 9th. BidaskClub cut Zebra Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, July 16th. Zacks Investment Research raised GALP ENERGIA SG/ADR from a “sell” rating to a “hold” rating in a research report on Monday, May 27th. Finally, ValuEngine raised ZIX from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 4th. Nine analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $53.77.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a positive return on equity of 8.99% and a negative net margin of 26.48%. The company had revenue of $946.20 million during the quarter, compared to analysts’ expectations of $925.13 million. During the same period last year, the firm posted $0.45 earnings per share. The business’s revenue was down 1.0% on a year-over-year basis. As a group, research analysts predict that DENTSPLY SIRONA Inc will post 2.35 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Stockholders of record on Friday, June 28th were given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.62%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date was Thursday, June 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 17.41%.
In other news, SVP Maureen J. Macinnis sold 54,402 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $55.00, for a total value of $2,992,110.00. Following the completion of the sale, the senior vice president now directly owns 50,962 shares of the company’s stock, valued at $2,802,910. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider William E. Newell sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $54.73, for a total value of $164,190.00. Following the completion of the sale, the insider now directly owns 28,212 shares of the company’s stock, valued at $1,544,042.76. The disclosure for this sale can be found here. Over the last ninety days, insiders bought 26,417 shares of company stock valued at $1,425,395 and sold 138,922 shares valued at $7,631,805. Company insiders own 0.62% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: How to Invest in Growth Stocks
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.